論文

査読有り 国際誌
2021年2月15日

Autosomal dominant diabetes associated with a novel ZYG11A mutation resulting in cell cycle arrest in beta-cells.

Molecular and cellular endocrinology
  • Chutima Charoensuk
  • Prapaporn Jungtrakoon Thamtarana
  • Chutima Chanprasert
  • Watip Tangjittipokin
  • Jun Shirakawa
  • Yu Togashi
  • Kazuki Orime
  • Pucharee Songprakhon
  • Chartchai Chaichana
  • Zuroida Abubakar
  • Paweena Ouying
  • Jatuporn Sujjitjoon
  • Alessandro Doria
  • Nattachet Plengvidhya
  • Pa-Thai Yenchitsomanus
  • 全て表示

522
開始ページ
111126
終了ページ
111126
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1016/j.mce.2020.111126

Diabetes is a genetically heterogeneous disease, for which we are aiming to identify causative genes. Here, we report a missense mutation (c.T1424C:p.L475P) in ZYG11A identified by exome sequencing as segregating with hyperglycemia in a Thai family with autosomal dominant diabetes. ZYG11A functions as a target recruitment subunit of an E3 ubiquitin ligase complex that plays an important role in the regulation of cell cycle. We demonstrate an increase in cells arrested at G2/mitotic phase among beta-cells deficient for ZYG11A or overexpressing L475P-ZYG11A, which is associated with a decreased growth rate. This is the first evidence linking a ZYG11A mutation to hyperglycemia, and suggesting ZYG11A as a cell cycle regulator required for beta-cell growth. Since most family members were either overweight or obese, but only mutation carriers developed hyperglycemia, our data also suggests the ZYG11A mutation as a genetic factor predisposing obese individuals to beta-cell failure in maintenance of glucose homeostasis.

リンク情報
DOI
https://doi.org/10.1016/j.mce.2020.111126
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/33321115
ID情報
  • DOI : 10.1016/j.mce.2020.111126
  • PubMed ID : 33321115

エクスポート
BibTeX RIS